CA-18C3

Janssen Research & Development, LLC · Phase 1 active Small molecule

At a glance

Generic name	CA-18C3
Sponsor	Janssen Research & Development, LLC
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CA-18C3 CI brief — competitive landscape report
CA-18C3 updates RSS · CI watch RSS
Janssen Research & Development, LLC portfolio CI